EQS — Adhoc: Ad hoc: Evotec announces preliminary nine — months 2026 results above market expectations, reaffirming full — year 2026 guidance
EQS-Ad-hoc: Evotec SE / Key word(s): Forecast / Other Ad hoc: Evotec announces preliminary nine-months 2026 results above market expectations, reaffirming full-year 2026 guidance 13-Oct-2026 / 22:37 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by 1 EQS News — a service of 2 EQS Group. The issuer is solely responsible for the content of this announcement. ══════════════════════════════════════════════════════════════════════════ Ad hoc: Evotec announces preliminary nine-months 2026 results above market expectations, reaffirming full-year 2026 guidance Hamburg, Germany — Evotec SE (NASDAQ: EVO; Frankfurt Prime Standard: EVT) today announced preliminary unaudited financial results for first nine months of 2026. Full financial results for the third quarter and the first nine months of 2026 will be published on November 5, 2026, as scheduled. Based on preliminary figures, Evotec expects Group revenues for the first nine months of 2026 of approximately €465.0 million and adjusted Group EBITDA of approximately -€42.8 million. These figures are above current market expectations, with the variance driven largely by the p
EQS-Ad-hoc: Evotec SE / Key word(s): Forecast / Other Ad hoc: Evotec announces preliminary nine-months 2026 results above market expectations, reaffirming full-year 2026 guidance 13-Oct-2026 / 22:37 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by 1 EQS News — a service of 2 EQS Group. The issuer is solely responsible for the content of this announcement.
══════════════════════════════════════════════════════════════════════════ Ad hoc: Evotec announces preliminary nine-months 2026 results above market expectations, reaffirming full-year 2026 guidance Hamburg, Germany — Evotec SE (NASDAQ: EVO; Frankfurt Prime Standard: EVT) today announced preliminary unaudited financial results for first nine months of 2026. Full financial results for the third quarter and the first nine months of 2026 will be published on November 5, 2026, as scheduled. 8 million. These figures are above current market expectations, with the variance driven largely by the phasing of consensus estimates.
Evotec reaffirms its full-year 2026 guidance, which projects Group revenues of approximately €570 to €610 million (€595 to €635 million at CER) and adjusted Group EBITDA of approximately -€70 to -€105 million (-€60 to -€90 million at CER). — End of the ad hoc release — Contact: Dr. com End of Inside Information ══════════════════════════════════════════════════════════════════════════ 13-Oct-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
com Internet: ISIN: DE0005664809 WKN: 566480 Indices: SDAX, TecDAX Listed: Regulated Market in Frankfurt (Prime Standard), Tradegate BSX; Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart; Nasdaq LEI Code: 529900F9KI6OYITO9B12 EQS News ID: 2415242 End of Announcement EQS News Service 2415242 13-Oct-2026 CET/CEST References Visible links 1. 2. 3.